Aurora Spine Corporation Announces Financial Results for Third Quarter

Written by Customer Service on November 19, 2020. Posted in Public Companies.

NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICESGross margin improves to 48%, revealing company on track with FY20 strategy of selling more proprietary productsCARLSBAD, Calif., Nov. 19, 2020 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (US: AROSF), a company focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies, today announced the financial results for the third quarter ended September 30, 2020. All figures are in U.S. dollars.Financial and Business HighlightsReported revenues of $2.4 million in Q3 2020, compared to $1.6M in Q2 and $2.3M in Q1. Compared to Q3 2019, it represents a decrease of 6%.Sequential improvement of gross margin to 48.0% in Q3, up from...

Lilis Energy Announces Confirmation of Modified Debtors’ Liquidating Chapter 11 Plan

Written by Customer Service on November 19, 2020. Posted in Public Companies.

FORT WORTH, Texas, Nov. 19, 2020 (GLOBE NEWSWIRE) — Lilis Energy, Inc. (OTC: LLEXQ) (the “Company”), an exploration and development company operating in the Permian Basin of West Texas and Southeastern New Mexico, today announced that the United States Bankruptcy Court for the Southern District of Texas, Houston Division (the “Bankruptcy Court”) entered an order on November 17, 2020, among other things, confirming the Modified Debtors’ First Amended Joint Liquidating Chapter 11 Plan (the “Plan”) which received the overwhelming support of all creditors.The Company expects that the effective date of the Plan ( the “Effective Date”) will be on or around December 1, 2020, assuming that all conditions precedent to the Plan’s effectiveness are satisfied or waived on or prior to such date, including the closing of the sale of substantially...

Amarin Shares Topline Data from Partner’s Pivotal Phase 3 Study of VASCEPA® (Icosapent Ethyl) in Mainland China

Written by Customer Service on November 19, 2020. Posted in Public Companies.

Significant Reduction in Triglyceride Levels Without Low-Density Lipoprotein Cholesterol (LDL-C) Increase Compared to Placebo and Safety Profile Similar to Placebo Achieved with 4 Grams Per Day Dose of Icosapent Ethyl in Chinese Patients with Very High Triglycerides (>500 mg/dL)Results Support Upcoming Submission by Partner, Edding, Seeking Regulatory Approval in ChinaDUBLIN, Ireland and BRIDGEWATER, N.J., Nov. 19, 2020 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today shared positive, statistically significant top-line results from Protocol Number EDPC003R01, a Phase 3 clinical trial of VASCEPA® (icosapent ethyl) conducted in China by Amarin partner, Edding. The study, which investigated VASCEPA as a treatment for patients with very high triglycerides (≥500 mg/dL), met its primary efficacy endpoint as defined in the...

Vornado Announces Pricing of Public Offering of $300 Million 5.25% Series N Cumulative Redeemable Preferred Shares

Written by Customer Service on November 19, 2020. Posted in Public Companies.

NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) — VORNADO REALTY TRUST (NYSE: VNO) today announced the pricing of a public offering of $300 million perpetual 5.25% Series N Cumulative Redeemable Preferred Shares, at a price of $25.00 per share, pursuant to an effective registration statement. The offering is expected to close November 24, 2020, subject to customary closing conditions. The Company may redeem the Series N Preferred Shares at a redemption price of $25.00 per share on and after November 24, 2025. BofA Securities, J.P. Morgan, Morgan Stanley, UBS Investment Bank and Wells Fargo Securities, acted as joint book-running managers.The Company will use the net proceeds for general business purposes.The offering is being made under the Company’s shelf registration statement filed with the Securities and Exchange Commission. A prospectus...

Cummins Westport Announces Changes to its Board of Directors and Management Team

Written by Customer Service on November 19, 2020. Posted in Public Companies.

VANCOUVER, British Columbia, Nov. 19, 2020 (GLOBE NEWSWIRE) — Cummins Westport Inc. (“CWI”) today announced changes to its Board of Directors and Management in accordance with the terms of the 50/50 Joint Venture Agreement between Cummins Inc. (NYSE:CMI) and Westport Fuel Systems Inc. (TSX:WPRT/NASDAQ:WPRT). The changes take effect January 1, 2021.Changes to the management team are:Tom Hodek has been appointed President of CWI. Tom was Director of Sales and Marketing for CWI and previously led the development of the latest generation of CWI’s ISX12N, L9N and B6.7N engines.Chad Mobley has been re-appointed as Controller of CWI.Gord Exel, President of CWI will be stepping down as President upon the completion of his term.Changes to the Board of Directors are:Jim Arthurs, Executive Vice President of Westport Fuel Systems Inc. has been...

TransAtlantic Petroleum Announces Third Quarter 2020 Financial Results and Provides an Operations Update

Written by Customer Service on November 19, 2020. Posted in Public Companies.

HAMILTON, Bermuda, Nov. 19, 2020 (GLOBE NEWSWIRE) — TransAtlantic Petroleum Ltd. (TSX: TNP) (NYSE American: TAT) (the “Company” or “TransAtlantic”) today announced its financial results for the quarter ended September 30, 2020 and provided an operations update. Additional information can be found on the Company’s website at http://www.transatlanticpetroleum.com.Pending MergerAs previously disclosed, on August 7, 2020, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which an affiliate of a group of holders (the “Preferred Shareholder Group”) representing 100% of the Company’s outstanding 12.0% Series A Convertible Redeemable Preferred Shares (“Series A Preferred Shares”) would acquire all of the outstanding common shares, par value $0.10 per share (“common shares”) for $0.13 per share...

UPDATE — El Pollo Loco Challenges QSR Category with Design-Forward Approach

Written by Customer Service on November 19, 2020. Posted in Public Companies.

COSTA MESA, Calif., Nov. 19, 2020 (GLOBE NEWSWIRE) — El Pollo Loco, Inc. (“El Pollo Loco” or “Company) (Nasdaq: LOCO), the nation’s leading fire-grilled chicken restaurant chain, today announced the company’s commitment to a design philosophy that will challenge the QSR category norms, with more modern and artistic design choices.Click here to scroll through a variety of El Pollo Loco’s designs.

Kane Biotech to Release Third Quarter 2020 Financial Results on November 26 – Conference Call to Follow

Written by Customer Service on November 19, 2020. Posted in Public Companies.

WINNIPEG, Manitoba, Nov. 19, 2020 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, will announce its third quarter 2020 financial results after market close on Thursday, November 26, 2020.Kane Biotech management will host a conference call at 4:30 p.m. ET on Monday Nov. 30, 2020 to review the financial results and discuss business developments in the period.The call will also be broadcast live and archived on the Company’s website at www.kanebiotech.com under “News/Events” in the Investors section.About Kane Biotech Inc.Kane Biotech is a biotechnology company engaged in the research, development and commercialization...

Operational and Financial Results for the Period Ended September 30, 2020

Written by Customer Service on November 19, 2020. Posted in Public Companies.

NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today reported operational and financial results for the first quarter ended September 30, 2020 (FY2021).Mesoblast has entered into an exclusive worldwide license and collaboration agreement with Novartis for the development, manufacture and commercialization of its lead mesenchymal stromal cell (MSC) product candidate, remestemcel-L, with an initial focus on the treatment of acute respiratory distress syndrome (ARDS), including that associated with COVID-19. Details of this transaction have been lodged in a separate announcement with the ASX and Nasdaq today. As foreshadowed following the capital raising in May 2020, Mesoblast increased its investment in both clinical development...

Methode Electronics to Announce Second Quarter Fiscal 2021 Results on Thursday, December 3, 2020

Written by Customer Service on November 19, 2020. Posted in Public Companies.

CHICAGO, Nov. 19, 2020 (GLOBE NEWSWIRE) — Methode Electronics, Inc. (NYSE: MEI), a global developer of custom engineered and application specific products and solutions, today announced it will release its second quarter fiscal 2021 results for the period ended October 31, 2020, on Thursday, December 3, 2020, before the market opens.Following the release, the company will conduct a conference call and webcast to review financial and operational highlights led by its President and Chief Executive Officer, Donald W. Duda, and Chief Financial Officer, Ron Tsoumas, at 10:00 a.m. CST.To participate in the conference call, please dial (877) 407-8031 (domestic) or (201) 689-8031 (international) at least five minutes prior to the start of the event. A simultaneous webcast can be accessed through the company’s website, www.methode.com, by...

Day: November 19, 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice